| 112326-4 | Inflammatory illness severity (Blood, calculated.mrna expression) | MICRO |
| 112327-2 | Hereditary idiopathic pulmonary fibrosis multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 112328-0 | Bone marrow failure multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 112329-8 | Combined humoral and cell-mediated immunodeficiency multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 11233-4 | Brompheniramine | DRUG/TOX |
| 112330-6 | Inborn errors of immunity multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 112331-4 | Phagocytic cell disorder and chronic granulomatous disease multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 11234-2 | Propoxyphene (Hair) | DRUG/TOX |
| 11235-9 | fentaNYL (Urine, qualitative) | DRUG/TOX |
| 11236-7 | Gemfibrozil | DRUG/TOX |
| 11237-5 | hydrALAZINE | DRUG/TOX |
| 11238-3 | Hydroxyalprazolam (Urine) | DRUG/TOX |
| 112387-6 | Guselkumab | DRUG/TOX |
| 11239-1 | hydrOXYzine (qualitative) | DRUG/TOX |
| 112390-0 | Mycoplasma sp DNA (Urine, qualitative, naa with probe detection) | MICRO |
| 112395-9 | Treponema pallidum DNA in Skin (qualitative, naa with probe detection) | MICRO |
| 112396-7 | Haemophilus ducreyi DNA in Skin (qualitative, naa with probe detection) | MICRO |
| 112397-5 | Cytomegalovirus DNA in Skin (qualitative, naa with probe detection) | MICRO |
| 112398-3 | Chlamydia trachomatis L1+L2+L3 DNA in Skin (qualitative, naa with probe detection) | MICRO |
| 112399-1 | Ureaplasma urealyticum DNA in Mouth (qualitative, naa with probe detection) | MICRO |
| 1124-7 | Le sup(x) Ab (qualitative) | BLDBK |
| 11240-9 | hydrOXYzine (Urine) | DRUG/TOX |
| 112400-7 | Ureaplasma parvum DNA in Mouth (qualitative, naa with probe detection) | MICRO |
| 112401-5 | Trichomonas vaginalis DNA in Mouth (qualitative, naa with probe detection) | MICRO |
| 112402-3 | Neisseria gonorrhoeae DNA in Mouth (qualitative, naa with probe detection) | MICRO |
| 112403-1 | Mycoplasma hominis DNA in Mouth (qualitative, naa with probe detection) | MICRO |
| 112404-9 | Mycolasma genitalium DNA in Mouth (qualitative, naa with probe detection) | MICRO |
| 112405-6 | Chlamydia trachomatis DNA in Mouth (qualitative, naa with probe detection) | MICRO |
| 112406-4 | Mycoplasma sp identified in Prostatic fluid (organism specific culture) | MICRO |
| 112408-0 | Rotavirus RNA (Stool, qualitative, naa with probe detection) | MICRO |
| 112409-8 | Borrelia burgdorferi 18kD IgM Ab (qualitative, immunoblot) | MICRO |
| 11241-7 | Hyoscyamine | DRUG/TOX |
| 112410-6 | Toxoplasma gondii IgM Ab (qualitative, immunoblot) | MICRO |
| 112411-4 | DAPTOmycin | DRUG/TOX |
| 112412-2 | Ezogabine | DRUG/TOX |
| 112413-0 | Hydroquinidine | DRUG/TOX |
| 112414-8 | Gallopamil | DRUG/TOX |
| 112415-5 | Flunarizine | DRUG/TOX |
| 112416-3 | N-desbutyl-dronedarone | DRUG/TOX |
| 112417-1 | Dronedarone | DRUG/TOX |
| 112418-9 | Bisoprolol | DRUG/TOX |
| 112419-7 | Aprindine | DRUG/TOX |
| 11242-5 | Mercaptopurine | DRUG/TOX |
| 112420-5 | Ajmaline | DRUG/TOX |
| 112421-3 | Beta aminoisobutyrate (lc/ms/ms) | DRUG/TOX |
| 112422-1 | Aspartate (lc/ms/ms) | DRUG/TOX |
| 112423-9 | Arginine (lc/ms/ms) | DRUG/TOX |
| 112424-7 | t(10;19)(10p11.21;19p13.3)(CUL2,KDM4B) fusion transcript or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.TRNLOC |
| 112425-4 | Standing time 1 day | CLIN |
| 112426-2 | Physical effort | CLIN |